Literature DB >> 22302261

The new era of APOL1-associated glomerulosclerosis.

Barry I Freedman, Carl D Langefeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22302261      PMCID： PMC3315674          DOI： 10.1093/ndt/gfr812

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  39 in total

1.  Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Mariana Murea; Lijun Ma; James D Otvos; Jolyn Turner; Peter A Antinozzi; Jasmin Divers; Pamela J Hicks; Donald W Bowden; Michael V Rocco; John S Parks
Journal:  Nephrol Dial Transplant       Date:  2011-09-19       Impact factor: 5.992

2.  Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Authors:  Meredith A Bostrom; W H Linda Kao; Man Li; Hanna E Abboud; Sharon G Adler; Sudha K Iyengar; Paul L Kimmel; Robert L Hanson; Susanne B Nicholas; Rebekah S Rasooly; John R Sedor; Josef Coresh; Orly F Kohn; David J Leehey; Denyse Thornley-Brown; Erwin P Bottinger; Michael S Lipkowitz; Lucy A Meoni; Michael J Klag; Lingyi Lu; Pamela J Hicks; Carl D Langefeld; Rulan S Parekh; Donald W Bowden; Barry I Freedman
Journal:  Am J Kidney Dis       Date:  2011-11-25       Impact factor: 8.860

3.  African American living-kidney donors should be screened for APOL1 risk alleles.

Authors:  David M Cohen; Anuja Mittalhenkle; David L Scott; Carlton J Young; Douglas J Norman
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

4.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

5.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

Authors:  Allison E Ashley-Koch; Emmanuel C Okocha; Melanie E Garrett; Karen Soldano; Laura M De Castro; Jude C Jonassaint; Eugene P Orringer; James R Eckman; Marilyn J Telen
Journal:  Br J Haematol       Date:  2011-09-13       Impact factor: 6.998

6.  Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population.

Authors:  Doron M Behar; Eynat Kedem; Saharon Rosset; Yonas Haileselassie; Shay Tzur; Zipi Kra-Oz; Walter G Wasser; Yotam Shenhar; Eduardo Shahar; Gamal Hassoun; Carcom Maor; Dawit Wolday; Shimon Pollack; Karl Skorecki
Journal:  Am J Nephrol       Date:  2011-10-03       Impact factor: 3.754

7.  The MYH9/APOL1 region and chronic kidney disease in European-Americans.

Authors:  Conall M O'Seaghdha; Rulan S Parekh; Shih-Jen Hwang; Man Li; Anna Köttgen; Josef Coresh; Qiong Yang; Caroline S Fox; W H Linda Kao
Journal:  Hum Mol Genet       Date:  2011-03-23       Impact factor: 6.150

8.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

9.  Genetic variation in APOL1 associates with younger age at hemodialysis initiation.

Authors:  Zahra Kanji; Camille E Powe; Julia B Wenger; Chunmei Huang; Elizabeth Ankers; Dorothy A Sullivan; Gina Collerone; Neil R Powe; Marcello Tonelli; Ishir Bhan; Andrea J Bernhardy; Salvatore Dibartolo; David Friedman; Giulio Genovese; Martin R Pollak; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

10.  Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.

Authors:  Barry I Freedman; Carl D Langefeld; Lingyi Lu; Jasmin Divers; Mary E Comeau; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Randall C Johnson; Nicholette D Palmer; Pamela J Hicks; Meredith A Bostrom; Jessica N Cooke; Caitrin W McDonough; Donald W Bowden
Journal:  PLoS Genet       Date:  2011-06-16       Impact factor: 5.917
View more
  10 in total

1.  Conceptual shifts needed to understand the dynamic interactions of genes, environment, epigenetics, social processes, and behavioral choices.

Authors:  Fatimah L C Jackson; Mihai D Niculescu; Robert T Jackson
Journal:  Am J Public Health       Date:  2013-08-08       Impact factor: 9.308

2.  APOL1 variants and kidney disease in people of recent African ancestry.

Authors:  Giulio Genovese; David J Friedman; Martin R Pollak
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

Review 3.  APOL1 and nephropathy progression in populations of African ancestry.

Authors:  Barry I Freedman
Journal:  Semin Nephrol       Date:  2013-09       Impact factor: 5.299

Review 4.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

Review 5.  APOL1 Kidney Disease Risk Variants: An Evolving Landscape.

Authors:  Patrick D Dummer; Sophie Limou; Avi Z Rosenberg; Jurgen Heymann; George Nelson; Cheryl A Winkler; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2015-05       Impact factor: 5.299

Review 6.  Hypertension in the teenager.

Authors:  Elizabeth I Anyaegbu; Vikas R Dharnidharka
Journal:  Pediatr Clin North Am       Date:  2013-10-30       Impact factor: 3.278

7.  Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.

Authors:  Carl D Langefeld; Jasmin Divers; Nicholas M Pajewski; Amret T Hawfield; David M Reboussin; Diane E Bild; George A Kaysen; Paul L Kimmel; Dominic S Raj; Ana C Ricardo; Jackson T Wright; John R Sedor; Michael V Rocco; Barry I Freedman
Journal:  Kidney Int       Date:  2014-07-16       Impact factor: 10.612

8.  CKD hotspots around the world: where, why and what the lessons are. A CKJ review series.

Authors:  Catalina Martín-Cleary; Alberto Ortiz
Journal:  Clin Kidney J       Date:  2014-11-13

9.  Notch4 activation aggravates NF-κB-mediated inflammation in HIV-1-associated nephropathy.

Authors:  Rajni Vaid Puri; Sireesha Yerrathota; Trisha Home; Jessica Y Idowu; V Praveen Chakravarthi; Christopher J Ward; Pravin C Singhal; Gregory B Vanden Heuvel; Timothy A Fields; Madhulika Sharma
Journal:  Dis Model Mech       Date:  2019-12-17       Impact factor: 5.758

10.  APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.

Authors:  Duncan B Johnstone; Vijay Shegokar; Deepak Nihalani; Yogendra Singh Rathore; Leena Mallik; Vasant Zare; H Omer Ikizler; Rajaram Powar; Lawrence B Holzman
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.